Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × Milnacipran × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Depression 1

Interventions

pembrolizumab 177 Gemcitabine 166 Paclitaxel 150 Carboplatin 134 Bevacizumab 126 Docetaxel 112 Cisplatin 112 Cyclophosphamide 109 Exercise 96 Nivolumab 92 Fluorouracil 87 Capecitabine 85 Dexamethasone 81 Irinotecan 74 Radiotherapy 68 Oxaliplatin 68 Pemetrexed 66 Leucovorin 63 Standard of Care 62 Cetuximab 59 Sorafenib 53 Erlotinib Hydrochloride 53 Drug Therapy 53 Blood Specimen Collection 51 Doxorubicin 50 trametinib 47 atezolizumab 47 Ipilimumab 46 Albumin-Bound Paclitaxel 43 venetoclax 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02783430 2025-12-16

KETAPAL

University Hospital, Lille

Phase 2/3 Completed

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡